M. W. Büchler

Activity of Gemcitabine and Continuous Infusion Fluorouracil in Advanced Pancreatic Cancer

Daniel Rauch, Ch. Maurer, Stefan Aebi et al. · Oncology · 2000 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +13

ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma

John P. Neoptolemos, M. W. Büchler, D. D. Stocken et al. · Journal of Clinical Oncology · 2009 · 30 citations

Medicine, Oncology, Pharmacotherapy +14

Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ

FH Schmitz-Winnenthal, Lourdes Escobedo, Philipp Beckhove et al. · International Journal of Oncology · 2006 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.

John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox et al. · Journal of Clinical Oncology · 2011 · 24 citations

Medicine, Oncology, Pharmacology +17

Activity of raltitrexed and gemcitabine in advanced pancreatic cancer

Elena Kralidis, Stefan Aebi, Helmut Friess et al. · Annals of Oncology · 2003 · 23 citations · Full text

Medicine, Oncology, Pharmacology +11